首页> 外文期刊>Diabetes technology & therapeutics >Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study
【24h】

Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study

机译:从闪光葡萄糖监测切换到高低血肿风险1型糖尿病患者中低血糖监测的连续葡萄糖监测:I HART CGM研究的延伸阶段

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The I HART CGM study showed that real-time continuous glucose monitoring (RT-CGM) has greater beneficial impact on hypoglycemia than intermittent flash glucose monitoring (flash) in adults with type 1 diabetes (T1D) at high risk. The impact of continuing RT-CGM or switching from flash to RT-CGM for another 8 weeks was then evaluated. Methods: Prospective randomized parallel group study with an extension phase. After a 2-week run-in with blinded CGM, participants were randomized to either RT-CGM or flash for 8 weeks. All participants were then given the option to continue with RT-CGM for another 8 weeks. Glycemic outcomes at 8 weeks are compared with the 16-week endpoint. Results: Forty adults with T1D on intensified multiple daily insulin injections and with impaired awareness of hypoglycemia or a recent episode of severe hypoglycemia were included (40% female, median [IQR] age 49.5 [37.5-63.5] years, diabetes duration 30.0 [21.0-36.5] years, HbA1c 56 [48-63] mmol/mol, and Gold Score 5 [4-5]), of whom 36 completed the final 16-week extension. There was a significant reduction in percentage time in hypoglycemia (3.0mmol/L) in the group switching from flash to RT-CGM (from 5.0 [3.7-8.6]% to 0.8 [0.4-1.9]%, P=0.0001), whereas no change was observed in the RT-CGM group continuing with the additional 8 weeks of RT-CGM (1.3 [0.4-2.8] vs. 1.3 [0.8-2.5], P=0.82). Time in target (3.9-10mmol/L) increased in the flash group after switching to RT-CGM (60.0 [54.5-67.8] vs. 67.4 [56.3-72.4], P=0.02) and remained the same in the RT-CGM group that continued with RT-CGM (65.9 [54.1-74.8] vs. 64.9 [49.2-73.9], P=0.64). Conclusions: Our data suggest that switching from flash to RT-CGM has a significant beneficial impact on hypoglycemia outcomes and that continued use of RT-CGM maintains hypoglycemia risk benefit in this high-risk population.
机译:背景:I HART CGM研究表明,实时连续葡萄糖监测(RT-CGM)对低血糖的影响比具有高风险的1型糖尿病(T1D)中的间歇闪光葡萄糖监测(闪光)对低血糖产生更大的有益影响。然后评价继续RT-CGM或从闪光切换到RT-CGM另外8周的影响。方法:延伸阶段预期随机平行群体研究。经过2周的盲目CGM后,参与者被随机化为RT-CGM或闪光8周。然后,所有参与者都可以选择另外8周继续使用RT-CGM。与16周的终点相比,8周的血糖结果。结果:含有T1D的四十个成年人加强多年日常胰岛素注射,并且患有对低血糖症的意识受损或最近的严重低血基血症发作(40%,中位数[IQR]年龄49.5年[37.5-63.5]年,糖尿病持续时间30.0 [21.0 -36.5]年,HBA1C 56 [48-63] Mmol / Mol,以及金得分5 [4-5]),其中36个完成了最终的16周延长。从闪光转移到RT-CGM的组中的低血糖(& 3.0mmol / L)中的百分比时间显着降低了(从5.0 [3.7-8.6]%到0.8 [0.4-1.9]%,p = 0.0001) ,而在RT-CGM组中没有观察到RT-CGM的另外的8周(1.3 [0.4-2.8],1.3 [0.8-2.5],P = 0.82)中没有任何变化。在切换到RT-CGM后,闪蒸组中的靶(3.9-10mmol / L)的时间(60.0 [54.5-67.8],67.4 [56.3-72.4],p = 0.02),在RT-CGM中保持不变继续使用RT-CGM(65.9 [54.1-74.8]与64.9 [49.2-73.9],p = 0.64)。结论:我们的数据表明,从闪光到RT-CGM切换对低血糖结果具有显着的有益影响,并且继续使用RT-CGM在这种高危人群中维持低血糖风险益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号